{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:52:08Z","timestamp":1791312728113,"version":"4.3.1"},"reference-count":341,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T00:00:00Z","timestamp":1776643200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2022-140169OB-C21"],"award-info":[{"award-number":["PID2022-140169OB-C21"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["101095679"],"award-info":[{"award-number":["101095679"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["HORIZON-HLTH2022-STAYHLTH-02"],"award-info":[{"award-number":["HORIZON-HLTH2022-STAYHLTH-02"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","award":["821283"],"award-info":[{"award-number":["821283"]}],"id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["IFI21\/00034"],"award-info":[{"award-number":["IFI21\/00034"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["CP22\/00050"],"award-info":[{"award-number":["CP22\/00050"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014440","name":"Gobierno de Espa\u00f1a Ministerio de Ciencia e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020098","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020098","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["RC-0005-2020"],"award-info":[{"award-number":["RC-0005-2020"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["CP23\/00088"],"award-info":[{"award-number":["CP23\/00088"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023731","name":"Consejer\u00eda de Salud y Consumo, Junta de Andaluc\u00eda","doi-asserted-by":"publisher","award":["RHJ-0052-2024"],"award-info":[{"award-number":["RHJ-0052-2024"]}],"id":[{"id":"10.13039\/501100023731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"Universidad de M\u00e1laga","doi-asserted-by":"publisher","award":["PPRO-CTS1032-G-2023"],"award-info":[{"award-number":["PPRO-CTS1032-G-2023"]}],"id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009473","name":"Universidad de M\u00e1laga","doi-asserted-by":"publisher","award":["PPRO-CTS649-G-2023"],"award-info":[{"award-number":["PPRO-CTS649-G-2023"]}],"id":[{"id":"10.13039\/100009473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["FORT23\/00013"],"award-info":[{"award-number":["FORT23\/00013"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.apsb.2026.04.014","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:38:58Z","timestamp":1777073938000},"page":"4233-4260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The gut\u2013liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8458-612X","authenticated-orcid":false,"given":"Irene","family":"D\u00edaz-Alberola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9068-0518","authenticated-orcid":false,"given":"Daniel E.","family":"Di Zeo-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0031-1437","authenticated-orcid":false,"given":"Vanesa","family":"Garrido-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"L\u00f3pez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Rodr\u00edguez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1565-0757","authenticated-orcid":false,"given":"Raul J.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9586-4896","authenticated-orcid":false,"given":"M. Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4728-201X","authenticated-orcid":false,"given":"Marina","family":"Villanueva-Paz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3491-2724","authenticated-orcid":false,"given":"Eduardo","family":"Garc\u00eda-Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.04.014_bib1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJMra1816149","article-title":"Drug-induced liver injury \u2014 types and phenotypes","volume":"381","author":"Hoofnagle","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib2","first-page":"331","article-title":"Immune mechanisms in acetaminophen-induced acute liver failure","volume":"3","author":"Krenkel","year":"2014","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.apsb.2026.04.014_bib3","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2026.04.014_bib4","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/liv.15821","article-title":"Anticancer drugs are the first cause of drug-induced liver injury in a reference hospital","volume":"44","author":"Pocurull","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1055\/s-0038-1623518","article-title":"Hepatic damage by natural remedies","volume":"38","author":"Andrade","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib6","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/antiox10030390","article-title":"Oxidative stress in drug-induced liver injury (DILI): from mechanisms to biomarkers for use in clinical practice","volume":"10","author":"Villanueva-Paz","year":"2021","journal-title":"Antioxidants"},{"key":"10.1016\/j.apsb.2026.04.014_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.3389\/fphar.2019.00837","article-title":"Mechanistic studies of idiosyncratic DILI: clinical implications","volume":"10","author":"Uetrecht","year":"2019","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib8","article-title":"Role and mechanism of gut microbiota in human disease","volume":"11","author":"Chen","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib9","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3390\/ijms20020395","article-title":"Gut\u2013liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib10","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1053\/j.gastro.2020.04.077","article-title":"Contribution of the intestinal microbiome and gut barrier to hepatic disorders","volume":"159","author":"Chopyk","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.04.014_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.hbpd.2023.06.008","article-title":"Contribution of gut microbiota to drug-induced liver injury","volume":"22","author":"Chu","year":"2023","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib12","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.7150\/ijbs.46405","article-title":"The gut\u2013liver axis in immune remodeling: new insight into liver diseases","volume":"16","author":"Yang","year":"2020","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib13","article-title":"Effectiveness of probiotics and prebiotics against acute liver injury: a meta-analysis","volume":"8","author":"Xu","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.apsb.2026.04.014_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0035-1571276","article-title":"Targeting dysbiosis for the treatment of liver disease","volume":"36","author":"Anand","year":"2016","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib15","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41522-022-00352-6","article-title":"Host-microbiome interactions: gut\u2013liver axis and its connection with other organs","volume":"8","author":"Anand","year":"2022","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.apsb.2026.04.014_bib16","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut\u2013liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib17","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MOG.0000000000001013","article-title":"The role of the microbiome in liver disease","volume":"40","author":"Sch\u00f6ler","year":"2024","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib18","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.3748\/wjg.v29.i11.1651","article-title":"Microbiome-liver crosstalk: a multihit therapeutic target for liver disease","volume":"29","author":"Kirundi","year":"2023","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib19","article-title":"Antibiotics enhancing drug-induced liver injury assessed for causality using Roussel Uclaf Causality Assessment Method: emerging role of gut microbiota dysbiosis","volume":"9","author":"Fu","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.apsb.2026.04.014_bib20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41522-024-00494-9","article-title":"On validly published names, correct names, and changes in the nomenclature of phyla and genera of prokaryotes: a guide for the perplexed","volume":"10","author":"Oren","year":"2024","journal-title":"npj Biofilms Microbiomes"},{"key":"10.1016\/j.apsb.2026.04.014_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1146\/annurev-immunol-070119-115104","article-title":"Interaction between the microbiota, epithelia, and immune cells in the intestine","volume":"38","author":"Kayama","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib22","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11739-023-03374-w","article-title":"Gut microbiota, intestinal permeability, and systemic inflammation: a narrative review","volume":"19","author":"Di Vincenzo","year":"2024","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib23","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1080\/17474124.2017.1343143","article-title":"The intestinal barrier: a fundamental role in health and disease","volume":"11","author":"Vancamelbeke","year":"2017","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib24","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.3390\/ijms24021470","article-title":"The gut\u2013vascular barrier as a new protagonist in intestinal and extraintestinal diseases","volume":"24","author":"Di Tommaso","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib25","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s12876-014-0189-7","article-title":"Intestinal permeability\u2014a new target for disease prevention and therapy","volume":"14","author":"Bischoff","year":"2014","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib27","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","article-title":"Human gut-associated lymphoid tissues (GALT); diversity, structure, and function","volume":"14","author":"M\u00f6rbe","year":"2021","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib28","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41422-020-0332-7","article-title":"Interaction between microbiota and immunity in health and disease","volume":"30","author":"Zheng","year":"2020","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib29","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nri2515","article-title":"The gut microbiota shapes intestinal immune responses during health and disease","volume":"9","author":"Round","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1038\/s41575-024-00974-5","article-title":"Hepatic immune regulation and sex disparities","volume":"21","author":"Burra","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib31","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1152\/physiol.00005.2020","article-title":"Gut microbiota in liver disease: what do we know and what do we not know?.","volume":"35","author":"Jiang","year":"2020","journal-title":"Physiology"},{"key":"10.1016\/j.apsb.2026.04.014_bib32","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/hep.27254","article-title":"Immune tolerance in liver disease","volume":"60","author":"Crispe","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1122632","article-title":"Acetaminophen-induced liver injury: molecular mechanism and treatments from natural products","volume":"14","author":"Liao","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib34","doi-asserted-by":"crossref","first-page":"3685","DOI":"10.1016\/j.apsb.2021.11.013","article-title":"Preclinical models of idiosyncratic drug-induced liver injury (iDILI): moving towards prediction","volume":"11","author":"Segovia-Zafra","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.04.014_bib35","doi-asserted-by":"crossref","first-page":"3381","DOI":"10.1007\/s00204-020-02885-1","article-title":"Drug induced liver injury: an update","volume":"94","author":"Garcia-Cortes","year":"2020","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib36","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/liv.13931","article-title":"The diagnosis and management of idiosyncratic drug-induced liver injury","volume":"39","author":"Hassan","year":"2019","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/03602532.2011.604086","article-title":"Central role of mitochondria in drug-induced liver injury","volume":"44","author":"Pessayre","year":"2012","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.apsb.2026.04.014_bib38","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/acs.chemrestox.9b00275","article-title":"Definition of the chemical and immunological signals involved in drug-induced liver injury","volume":"33","author":"Ali","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib39","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1124\/pharmrev.120.000090","article-title":"The emerging role of the innate immune response in idiosyncratic drug reactions","volume":"73","author":"Sernoskie","year":"2021","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2026.04.014_bib40","doi-asserted-by":"crossref","first-page":"4557","DOI":"10.3390\/ijms22094557","article-title":"Immune-mediated drug-induced liver injury: immunogenetics and experimental models","volume":"22","author":"Gerussi","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib41","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/cts.13424","article-title":"Genetics of drug-induced liver injury: current knowledge and future prospects","volume":"16","author":"Daly","year":"2023","journal-title":"Clin Transl Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib42","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.3390\/ijms22062954","article-title":"Idiosyncratic drug-induced liver injury: mechanistic and clinical challenges","volume":"22","author":"Jee","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1146\/annurev.pharmtox.47.120505.105150","article-title":"Idiosyncratic drug reactions: current understanding","volume":"47","author":"Uetrecht","year":"2007","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.202000267","article-title":"Drug hapten-specific T-cell activation: current status and unanswered questions","volume":"21","author":"Adair","year":"2021","journal-title":"Proteomics"},{"key":"10.1016\/j.apsb.2026.04.014_bib45","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1002\/cpt.2423","article-title":"Lymphocyte profile and immune checkpoint expression in drug-induced liver injury: an immunophenotyping study","volume":"110","author":"Cueto-Sanchez","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.04.014_bib46","doi-asserted-by":"crossref","first-page":"56","DOI":"10.37349\/edd.2023.00018","article-title":"Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions","volume":"2","author":"Cueto-S\u00e1nchez","year":"2023","journal-title":"Explor Dig Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/liv.12988","article-title":"Mechanisms of adaptation and progression in idiosyncratic drug induced liver injury, clinical implications","volume":"36","author":"Dara","year":"2016","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib48","first-page":"145","article-title":"Immune mechanisms of idiosyncratic drug-induced liver injury","volume":"3","author":"Mak","year":"2017","journal-title":"JDR Clin Transl Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib49","series-title":"Understanding Hepatotoxicity-Causes, symptoms and Prevention","article-title":"Modulating the gut microbiota to combat drug-induced liver injury: a new frontier in hepatic health","author":"Yang","year":"2025"},{"key":"10.1016\/j.apsb.2026.04.014_bib50","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/hep.29327","article-title":"The liver\u2013gut microbiota axis modulates hepatotoxicity of tacrine in the rat","volume":"67","author":"Yip","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib51","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01596-21","article-title":"Akkermansia muciniphila ameliorates acetaminophen-induced liver injury by regulating gut microbial composition and metabolism","volume":"10","author":"Xia","year":"2022","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.apsb.2026.04.014_bib52","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.3390\/nu14132636","article-title":"Broussonetia papyrifera polysaccharide alleviated acetaminophen-induced liver injury by regulating the intestinal flora","volume":"14","author":"Xu","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.014_bib53","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.2147\/DDDT.S381667","article-title":"Integrated microbiome and metabolome analysis reveals correlations between gut microbiota components and metabolic profiles in mice with methotrexate-induced hepatoxicity","volume":"16","author":"Wang","year":"2022","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.apsb.2026.04.014_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598170","article-title":"Gut microbiota participates in antithyroid drug induced liver injury through the lipopolysaccharide related signaling pathway","volume":"11","author":"Sun","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1512815","article-title":"The association between the gut microbiome and antituberculosis drug-induced liver injury","volume":"16","author":"Pei","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114400","article-title":"Gut microbiota affects sensitivity to immune-mediated isoniazid-induced liver injury","volume":"160","author":"Liu","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.04.014_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106348","article-title":"Microbiota diversity in nonalcoholic fatty liver disease and in drug-induced liver injury","volume":"182","author":"Rodriguez-Diaz","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib58","article-title":"Combined analysis of 16S rDNA sequencing and metabolomics to find biomarkers of drug-induced liver injury","volume":"13","author":"He","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib59","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.3390\/ijms25136863","article-title":"Idiosyncratic drug-induced liver injury and amoxicillin\u2013clavulanate: spotlight on gut microbiota, fecal metabolome and bile acid profile in patients","volume":"25","author":"Rom\u00e1n-Sag\u00fcillo","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib60","article-title":"Alteration of bile acids and omega-6 PUFAs are correlated with the progression and prognosis of drug-induced liver injury","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib61","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s40495-019-00200-w","article-title":"Microbiome is a functional modifier of P450 drug metabolism","volume":"5","author":"Dempsey","year":"2019","journal-title":"Curr Pharmacol Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib62","doi-asserted-by":"crossref","first-page":"5057","DOI":"10.3390\/ijms23095057","article-title":"Contrasting health effects of Bacteroidetes and Firmicutes lies in their genomes: analysis of P450s, ferredoxins, and secondary metabolite clusters","volume":"23","author":"Nkosi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib63","article-title":"Gut microbiota and chemical-induced acute liver injury","volume":"12","author":"Chen","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib64","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.126707","article-title":"Gut microbiota exaggerates triclosan-induced liver injury via gut\u2013liver axis","volume":"421","author":"Zhang","year":"2022","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.apsb.2026.04.014_bib65","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41572-019-0105-0","article-title":"Drug-induced liver injury","volume":"5","author":"Andrade","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.apsb.2026.04.014_bib66","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmgh.2020.11.002","article-title":"Intestinal dysbiosis amplifies acetaminophen-induced acute liver injury","volume":"11","author":"Schneider","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib67","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF02977800","article-title":"Hepatoprotective effect of lactic acid bacteria, inhibitors of \u03b2-glucuronidase production against intestinal microflora","volume":"28","author":"Han","year":"2005","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.apsb.2026.04.014_bib68","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12866-016-0862-9","article-title":"Lactobacillus acidophilus alleviates the inflammatory response to enterotoxigenic Escherichia coli K88 via inhibition of the NF-\u03baB and p38 mitogen-activated protein kinase signaling pathways in piglets","volume":"16","author":"Li","year":"2016","journal-title":"BMC Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib69","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.apsb.2026.04.014_bib70","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1530\/EC-19-0001","article-title":"Alteration of the intestinal flora may participate in the development of Graves' disease: a study conducted among the Han population in southwest China","volume":"8","author":"Yang","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/j.apsb.2026.04.014_bib71","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s40618-019-1010-9","article-title":"Alterations in the intestinal microbiota of patients with severe and active Graves' orbitopathy: a cross-sectional study","volume":"42","author":"Shi","year":"2019","journal-title":"J Endocrinol Investig"},{"key":"10.1016\/j.apsb.2026.04.014_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemosphere.2020.129004","article-title":"Perfluorooctanoic acid-induced liver injury is potentially associated with gut microbiota dysbiosis","volume":"266","author":"Wang","year":"2021","journal-title":"Chemosphere"},{"key":"10.1016\/j.apsb.2026.04.014_bib73","doi-asserted-by":"crossref","DOI":"10.4254\/wjh.v17.i5.106618","article-title":"Acute liver failure from anti-tuberculosis drug-induced liver injury: an update","volume":"17","author":"Kumar","year":"2025","journal-title":"World J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib74","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s40168-017-0286-2","article-title":"Longitudinal profiling reveals a persistent intestinal dysbiosis triggered by conventional anti-tuberculosis therapy","volume":"5","author":"Namasivayam","year":"2017","journal-title":"Microbiome"},{"key":"10.1016\/j.apsb.2026.04.014_bib75","doi-asserted-by":"crossref","first-page":"9444","DOI":"10.3390\/ijms24119444","article-title":"Regulation of gut microflora by Lactobacillus casei Zhang attenuates liver injury in mice caused by anti-tuberculosis drugs","volume":"24","author":"Li","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib76","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1002\/eji.202048556","article-title":"Intestinal microbiota disruption limits the isoniazid mediated clearance of Mycobacterium tuberculosis in mice","volume":"50","author":"Negi","year":"2020","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib77","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.01.029","article-title":"Comprehensive analysis and insights gained from long-term experience of the Spanish DILI Registry","volume":"75","author":"Stephens","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144854","article-title":"Antibiotic treatment affects intestinal permeability and gut microbial composition in Wistar rats dependent on antibiotic class","volume":"10","author":"Tulstrup","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.014_bib79","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftaa041","article-title":"Hepatic dysfunction induced by intestinal dysbacteriosis mainly manifests as immunologic abnormity in mice","volume":"78","author":"Luo","year":"2020","journal-title":"Pathog Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib80","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/gutjnl-2018-317836","article-title":"Alterations of gut microbiome in autoimmune hepatitis","volume":"69","author":"Wei","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.04.014_bib81","article-title":"Serum metabolome and targeted bile acid profiling reveals potential novel biomarkers for drug-induced liver injury","volume":"98","author":"Ma","year":"2019","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.apsb.2026.04.014_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1432049","article-title":"Gut microbiota causally affects drug-induced liver injury via plasma metabolites: a Mendelian randomization study","volume":"15","author":"Fu","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib83","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.cell.2019.12.025","article-title":"Establishing or exaggerating causality for the gut microbiome: lessons from human microbiota-associated rodents","volume":"180","author":"Walter","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.04.014_bib84","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1517\/17425255.2016.1121234","article-title":"The influence of gut microbiota on drug metabolism and toxicity","volume":"12","author":"Li","year":"2016","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib85","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s13238-018-0547-2","article-title":"Pharmacomicrobiomics: a novel route towards personalized medicine?.","volume":"9","author":"Doestzada","year":"2018","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2026.04.014_bib86","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s12272-012-0418-y","article-title":"Role of metabolism by human intestinal microflora in geniposide induced toxicity in HepG2 cells","volume":"35","author":"Kang","year":"2012","journal-title":"Arch Pharm Res (Seoul)"},{"key":"10.1016\/j.apsb.2026.04.014_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153656","article-title":"Compatibility with semen sojae praeparatum attenuates hepatotoxicity of gardeniae fructus by regulating the microbiota, promoting butyrate production and activating antioxidant response","volume":"90","author":"Luo","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.apsb.2026.04.014_bib88","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/CM9.0000000000000651","article-title":"Gut microbiota and drug-induced liver injury: an update","volume":"133","author":"Niu","year":"2020","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.apsb.2026.04.014_bib89","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2231590","article-title":"Phenylpropionic acid produced by gut microbiota alleviates acetaminophen-induced hepatotoxicity","volume":"15","author":"Cho","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.apsb.2026.04.014_bib90","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.tips.2013.01.009","article-title":"Regulation of drug-induced liver injury by signal transduction pathways: critical role of mitochondria","volume":"34","author":"Han","year":"2013","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib91","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2018.02.024","article-title":"Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice","volume":"69","author":"Gong","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib92","doi-asserted-by":"crossref","first-page":"14728","DOI":"10.1073\/pnas.0904489106","article-title":"Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism","volume":"106","author":"Clayton","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.04.014_bib93","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.658354","article-title":"Impact of bacterial metabolites on gut barrier function and host immunity: a focus on bacterial metabolism and its relevance for intestinal inflammation","volume":"12","author":"Gasaly","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib94","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1124\/dmd.123.001541","article-title":"The discovery of gut microbial metabolites as modulators of host susceptibility to acetaminophen-induced hepatotoxicity","volume":"52","author":"Lee","year":"2024","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.apsb.2026.04.014_bib95","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41575-023-00771-6","article-title":"Gut\u2013liver axis: barriers and functional circuits","volume":"20","author":"Pabst","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib96","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/j.tim.2021.02.001","article-title":"Microbial regulation of host physiology by short-chain fatty acids","volume":"29","author":"van der Hee","year":"2021","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib97","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4110\/in.2014.14.6.277","article-title":"Gut microbiota-derived short-chain fatty acids, T cells, and inflammation","volume":"14","author":"Kim","year":"2014","journal-title":"Immune Netw"},{"key":"10.1016\/j.apsb.2026.04.014_bib98","doi-asserted-by":"crossref","first-page":"9985","DOI":"10.12998\/wjcc.v10.i28.9985","article-title":"Role of short chain fatty acids in gut health and possible therapeutic approaches in inflammatory bowel diseases","volume":"10","author":"Caetano","year":"2022","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.apsb.2026.04.014_bib99","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1126\/science.1241165","article-title":"The microbial metabolites, short-chain fatty acids, regulate colonic T reg cell homeostasis","volume":"341","author":"Smith","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.04.014_bib100","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/liv.15512","article-title":"Ampicillin exacerbates acetaminophen-induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction","volume":"43","author":"Li","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib101","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s13105-017-0568-y","article-title":"Sodium butyrate protects against oxidative stress in HepG2 cells through modulating Nrf2 pathway and mitochondrial function","volume":"73","author":"Xing","year":"2016","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.apsb.2026.04.014_bib102","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.taap.2018.09.014","article-title":"Regulatory crosstalk between the oxidative stress-related transcription factor Nfe2l2\/Nrf2 and mitochondria","volume":"359","author":"Ryoo","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib103","doi-asserted-by":"crossref","first-page":"3625","DOI":"10.1016\/j.molimm.2007.04.010","article-title":"Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF\u03baB signalling","volume":"44","author":"Schwab","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib104","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1158\/0008-5472.CAN-08-4466","article-title":"GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon","volume":"69","author":"Thangaraju","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib105","doi-asserted-by":"crossref","first-page":"8680","DOI":"10.1021\/acs.jafc.2c02950","article-title":"Bifidobacterium longum BL-10 with antioxidant capacity ameliorates lipopolysaccharide-induced acute liver injury in mice by the nuclear factor-\u03baB pathway","volume":"70","author":"Dong","year":"2022","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.apsb.2026.04.014_bib106","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/jgh.15899","article-title":"The effect of increasing intestinal short-chain fatty acid concentration on gut permeability and liver injury in the context of liver disease: a systematic review","volume":"37","author":"Pohl","year":"2022","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib107","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s10620-012-2259-4","article-title":"Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein claudin-1 transcription","volume":"57","author":"Wang","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775526","article-title":"The Gut\u2013liver axis in health and disease: the role of gut microbiota-derived signals in liver injury and regeneration","volume":"12","author":"Zheng","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib109","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2012.06553.x","article-title":"Microbial butyrate and its role for barrier function in the gastrointestinal tract","volume":"1258","author":"Pl\u00f6ger","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib110","doi-asserted-by":"crossref","first-page":"s4","DOI":"10.5604\/01.3001.0010.5493","article-title":"Bile acid physiology","volume":"16","author":"Di Ciaula","year":"2017","journal-title":"Ann Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib111","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.bbadis.2018.05.011","article-title":"Animal models to study bile acid metabolism","volume":"1865","author":"Li","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib112","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clinre.2015.12.017","article-title":"Bile acids in drug induced liver injury: key players and surrogate markers","volume":"40","author":"Schadt","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib113","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","article-title":"Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology","volume":"19","author":"Fuchs","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib114","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.livres.2017.05.001","article-title":"Bile acid metabolism and signaling in liver disease and therapy","volume":"1","author":"Chiang","year":"2017","journal-title":"Liver Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","article-title":"Consequences of bile salt biotransformations by intestinal bacteria","volume":"7","author":"Ridlon","year":"2016","journal-title":"Gut Microbes"},{"key":"10.1016\/j.apsb.2026.04.014_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2022.111618","article-title":"Discovery of farnesoid X receptor and its role in bile acid metabolism","volume":"548","author":"Chiang","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.apsb.2026.04.014_bib117","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.emboj.7601049","article-title":"Endocrine functions of bile acids","volume":"25","author":"Houten","year":"2006","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2026.04.014_bib118","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib119","doi-asserted-by":"crossref","first-page":"G554","DOI":"10.1152\/ajpgi.00223.2019","article-title":"Bile acid receptors FXR and TGR5 signaling in fatty liver diseases and therapy","volume":"318","author":"Chiang","year":"2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib120","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/gut.2010.212159","article-title":"Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease","volume":"60","author":"Gadaleta","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.04.014_bib121","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/metabo11120852","article-title":"Targeted metabolomics analysis of bile acids in patients with idiosyncratic drug-induced liver injury","volume":"11","author":"Xie","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.apsb.2026.04.014_bib122","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193824","article-title":"Assessment of serum bile acid profiles as biomarkers of liver injury and liver disease in humans","volume":"13","author":"Luo","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.014_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2021.126707","article-title":"Gut microbiota exaggerates triclosan-induced liver injury via gut\u2013liver axis","volume":"421","author":"Zhang","year":"2022","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.apsb.2026.04.014_bib124","doi-asserted-by":"crossref","first-page":"S93","DOI":"10.1016\/S0168-8278(25)00464-7","article-title":"FRI-143-YI metabolomic profiling to differentiate drug-induced liver injury from other liver diseases using machine learning models","volume":"82","author":"Zeo-S\u00e1nchez","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib125","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.taap.2017.11.007","article-title":"Individual serum bile acid profiling in rats aids in human risk assessment of drug-induced liver injury due to BSEP inhibition","volume":"338","author":"Cepa","year":"2018","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib126","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/toxsci\/kft221","article-title":"Evaluation of serum bile acid profiles as biomarkers of liver injury in rodents","volume":"137","author":"Luo","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib127","doi-asserted-by":"crossref","DOI":"10.1007\/s00204-021-03114-z","article-title":"Metabolomic analysis to discriminate drug-induced liver injury (DILI) phenotypes","volume":"95","author":"Quint\u00e1s","year":"2021","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2020.06.067","article-title":"A high serum level of taurocholic acid is correlated with the severity and resolution of drug-induced liver injury","volume":"19","author":"Tian","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/toxsci\/kfu195","article-title":"Glycodeoxycholic acid levels as prognostic biomarker in acetaminophen-induced acute liver failure patients","volume":"142","author":"Woolbright","year":"2014","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106229","article-title":"Usefulness of plasma bile acid profile as a prognostic biomarker for drug-induced liver injury","author":"Monte","year":"2026","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2026.04.014_bib131","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.clinre.2015.12.017","article-title":"Bile acids in drug induced liver injury: key players and surrogate markers","volume":"40","author":"Schadt","year":"2016","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib132","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/cpt.1222","article-title":"Can bile salt export pump inhibition testing in drug discovery and development reduce liver injury risk? An international transporter consortium perspective","volume":"104","author":"Kenna","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.04.014_bib133","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1124\/dmd.111.040758","article-title":"In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans","volume":"40","author":"Dawson","year":"2012","journal-title":"Drug Metab Disp"},{"key":"10.1016\/j.apsb.2026.04.014_bib134","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2024.1341938","article-title":"Regulating bile acids signaling for NAFLD: molecular insights and novel therapeutic interventions","volume":"15","author":"Wei","year":"2024","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib135","doi-asserted-by":"crossref","first-page":"433","DOI":"10.4254\/wjh.v13.i4.433","article-title":"Bile acid indices as biomarkers for liver diseases I: diagnostic markers","volume":"13","author":"Alamoudi","year":"2021","journal-title":"World J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib136","doi-asserted-by":"crossref","first-page":"G685","DOI":"10.1152\/ajpgi.00207.2004","article-title":"Cytokine regulation of human sterol 12\u03b1-hydroxylase (CYP8B1) gene","volume":"288","author":"Jahan","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib137","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.toxlet.2024.05.015","article-title":"Ibuprofen induces hepatic Cyp7a1 expression in mice via the intestinal FXR\u2013FGF15 signaling","volume":"398","author":"Li","year":"2024","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.apsb.2026.04.014_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102719","article-title":"Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor","volume":"54","author":"Gadaleta","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.apsb.2026.04.014_bib139","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.chom.2022.02.004","article-title":"Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis","volume":"30","author":"Cai","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2026.04.014_bib140","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/hep.27265","article-title":"Serum mitochondrial biomarkers and damage-associated molecular patterns are higher in acetaminophen overdose patients with poor outcome","volume":"60","author":"Mcgill","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib141","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mam.2017.06.001","article-title":"Mechanisms of bile acid mediated inflammation in the liver","volume":"56","author":"Li","year":"2017","journal-title":"Mol Aspect Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib142","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1681\/ASN.2014121271","article-title":"G protein-coupled bile acid receptor TGR5 activation inhibits kidney disease in obesity and diabetes","volume":"27","author":"Wang","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.apsb.2026.04.014_bib143","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal Transduct Targeted Ther"},{"key":"10.1016\/j.apsb.2026.04.014_bib144","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2012.09.055","article-title":"The receptor TGR5 mediates the prokinetic actions of intestinal bile acids and is required for normal defecation in mice","volume":"144","author":"Alemi","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.04.014_bib145","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.04.014_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2024.116462","article-title":"Update on the development of TGR5 agonists for human diseases","volume":"271","author":"Jin","year":"2024","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.apsb.2026.04.014_bib147","article-title":"TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload","volume":"3","author":"Bidault-Jourdainne","year":"2021","journal-title":"JHEP Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib148","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1631\/jzus.B1900073","article-title":"Regulation of bile acid metabolism-related signaling pathways by gut microbiota in diseases","volume":"20","author":"Jia","year":"2019","journal-title":"J Zhejiang Univ - Sci B"},{"key":"10.1016\/j.apsb.2026.04.014_bib149","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","article-title":"Bile acids activated receptors regulate innate immunity","volume":"9","author":"Fiorucci","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib150","article-title":"The immunological mechanisms and immune-based biomarkers of drug-induced liver injury","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib151","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular carcinoma immune landscape and the potential of immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib152","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.3389\/fimmu.2018.01969","article-title":"Type II NKT cells: an elusive population with immunoregulatory properties","volume":"9","author":"Singh","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib153","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jcmgh.2019.06.003","article-title":"GPBAR1 functions as gatekeeper for liver NKT cells and provides counterregulatory signals in mouse models of immune-mediated hepatitis","volume":"8","author":"Biagioli","year":"2019","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib154","doi-asserted-by":"crossref","first-page":"7259","DOI":"10.1038\/srep07259","article-title":"Natural killer T cells play a necessary role in modulating of immune-mediated liver injury by gut microbiota","volume":"4","author":"Chen","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib155","doi-asserted-by":"crossref","first-page":"6657","DOI":"10.4049\/jimmunol.0901347","article-title":"The bile acid sensor farnesoid X receptor is a modulator of liver immunity in a rodent model of acute hepatitis","volume":"183","author":"Mencarelli","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib156","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1111\/bcp.15724","article-title":"Evaluation of diagnostic and prognostic candidate biomarkers in drug-induced liver injury vs. other forms of acute liver damage","volume":"89","author":"Cueto-S\u00e1nchez","year":"2023","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib157","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/00365520510024061","article-title":"Serum osteopontin levels in patients with acute liver dysfunction","volume":"41","author":"Arai","year":"2006","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib158","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jhep.2016.07.009","article-title":"Liver sinusoidal endothelial cells: physiology and role in liver diseases","volume":"66","author":"Poisson","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib159","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.954869","article-title":"The immune response as a therapeutic target in non-alcoholic fatty liver disease","volume":"13","author":"Ortiz-L\u00f3pez","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib160","article-title":"Modulation of gut microbiota by magnesium isoglycyrrhizinate mediates enhancement of intestinal barrier function and amelioration of methotrexate-induced liver injury","volume":"13","author":"Xia","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib161","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1038\/ismej.2012.6","article-title":"Microbes inside from diversity to function: the case of Akkermansia","volume":"6","author":"Belzer","year":"2012","journal-title":"ISME J"},{"key":"10.1016\/j.apsb.2026.04.014_bib162","doi-asserted-by":"crossref","first-page":"3655","DOI":"10.1128\/AEM.04050-14","article-title":"Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer","volume":"81","author":"Reunanen","year":"2015","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib163","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3389\/fmicb.2017.01804","article-title":"Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model","volume":"8","author":"Wu","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib164","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1242\/jcs.193482","article-title":"The mucosal barrier at a glance","volume":"130","author":"France","year":"2017","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib165","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jim.2014.12.015","article-title":"Methods to determine intestinal permeability and bacterial translocation during liver disease","volume":"421","author":"Wang","year":"2015","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.apsb.2026.04.014_bib166","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.3390\/cells9081909","article-title":"The intestinal barrier and current techniques for the assessment of gut permeability","volume":"9","author":"Schoultz","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.04.014_bib167","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1002\/hep4.1406","article-title":"Acetaminophen intoxication rapidly induces apoptosis of intestinal crypt stem cells and enhances intestinal permeability","volume":"3","author":"Chopyk","year":"2019","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.apsb.2026.04.014_bib168","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ajpath.2019.09.009","article-title":"Intestinal epithelial chemokine (C\u2013C Motif) ligand 7 overexpression enhances acetaminophen-induced hepatotoxicity in mice","volume":"190","author":"Niu","year":"2020","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2026.04.014_bib169","doi-asserted-by":"crossref","first-page":"5303","DOI":"10.1111\/bph.70123","article-title":"Intestinal permeability and immune-inflammatory markers in patients with idiosyncratic drug-induced liver injury, drug-induced steatosis and metabolic dysfunction\u2013associated steatotic liver disease (MASLD)","volume":"182","author":"Di Zeo-S\u00e1nchez","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib170","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1152\/physrev.00003.2008","article-title":"Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer","volume":"91","author":"Fasano","year":"2011","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.04.014_bib171","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s43066-024-00351-6","article-title":"Value of zonulin as a diagnostic and prognostic marker in different degrees of nonalcoholic fatty liver disease","volume":"14","author":"ElGhandour","year":"2024","journal-title":"Egypt Liver J"},{"key":"10.1016\/j.apsb.2026.04.014_bib172","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0002-9440(10)62264-X","article-title":"Interferon-\u03b3 and tumor necrosis factor-\u03b1 synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression","volume":"166","author":"Wang","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.apsb.2026.04.014_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103331","article-title":"Cytokines and intestinal epithelial permeability: a systematic review","volume":"22","author":"Meyer","year":"2023","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.apsb.2026.04.014_bib174","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.cmet.2015.03.001","article-title":"Regulation of obesity-related insulin resistance with gut anti-inflammatory agents","volume":"21","author":"Luck","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.04.014_bib175","first-page":"847","article-title":"Decreased levels of serum zonulin and copeptin in chronic Hepatitis-B patients","volume":"35","author":"Calgin","year":"2019","journal-title":"Pakistan J Med Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156727","article-title":"Growth differentiation factor 15: emerging role in liver diseases","volume":"182","author":"Li","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.apsb.2026.04.014_bib177","doi-asserted-by":"crossref","first-page":"363","DOI":"10.4093\/dmj.2020.0087","article-title":"The role of growth differentiation factor 15 in energy metabolism","volume":"44","author":"Chang","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/j.apsb.2026.04.014_bib178","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i41.110955","article-title":"Growth differentiation factor 15 alters intestinal barrier and increases permeability: a new molecular target in inflammatory bowel disease","volume":"31","author":"Ruiz-Malag\u00f3n","year":"2025","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib179","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/bcpt.13834","article-title":"Growth differentiation factor 15 is dispensable for acetaminophen-induced liver injury in mice","volume":"132","author":"Jiang","year":"2023","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"1","key":"10.1016\/j.apsb.2026.04.014_bib180","first-page":"1","article-title":"Growth differentiation factor 15 ameliorates nonalcoholic steatohepatitis and related metabolic disorders in mice","volume":"8","author":"Kim","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib181","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/s42003-023-04965-1","article-title":"Stress-responsive Gdf15 counteracts renointestinal toxicity via autophagic and microbiota reprogramming","volume":"6","author":"Ray","year":"2023","journal-title":"Commun Biol"},{"key":"10.1016\/j.apsb.2026.04.014_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2017.03.002","article-title":"Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction","volume":"21","author":"Thevaranjan","year":"2017","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.apsb.2026.04.014_bib183","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12072-010-9219-x","article-title":"The role of lipopolysaccharide\/toll-like receptor 4 signaling in chronic liver diseases","volume":"4","author":"Soares","year":"2010","journal-title":"Hepatol Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib184","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1038\/emm.2013.97","article-title":"Recognition of lipopolysaccharide pattern by TLR4 complexes","volume":"45","author":"Park","year":"2013","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib185","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s11605-021-05188-7","article-title":"The role of gut-derived lipopolysaccharides and the intestinal barrier in fatty liver diseases","volume":"26","author":"An","year":"2022","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/j.apsb.2026.04.014_bib186","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.3390\/ijms25052472","article-title":"Endotoxin inflammatory action on cells by dysregulated-immunological-barrier-linked ROS-apoptosis mechanisms in gut\u2013liver axis","volume":"25","author":"Dumitru","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib187","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3389\/fmicb.2018.00061","article-title":"Intestinal microbiome shifts, dysbiosis, inflammation, and non-alcoholic fatty liver disease","volume":"9","author":"Saltzman","year":"2018","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib188","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0168-8278(95)80424-2","article-title":"Endotoxemia in patients with chronic liver diseases: relationship to severity of liver diseases, presence of esophaegeal varices, and hyperdynamic circulation","volume":"22","author":"Lin","year":"1995","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib189","first-page":"689","article-title":"Gut microbiota and cytokine profile in cirrhosis","volume":"12","author":"Efremova","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib190","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1124\/jpet.106.110247","article-title":"Modest inflammation enhances diclofenac hepatotoxicity in rats: role of neutrophils and bacterial translocation","volume":"319","author":"Deng","year":"2006","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2026.04.014_bib191","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.3390\/ph15091130","article-title":"Magnesium isoglycyrrhizinate attenuates anti-tuberculosis drug-induced liver injury by enhancing intestinal barrier function and inhibiting the LPS\/TLRs\/NF-\u03baB signaling pathway in mice","volume":"15","author":"Gong","year":"2022","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.apsb.2026.04.014_bib192","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1002\/lt.23655","article-title":"Role of toll-like receptor 4 in mediating multiorgan dysfunction in mice with acetaminophen induced acute liver failure","volume":"19","author":"Shah","year":"2013","journal-title":"Liver Transplant"},{"key":"10.1016\/j.apsb.2026.04.014_bib193","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000337585","article-title":"Reduced hepatic injury in toll-like receptor 4-deficient mice following D-galactosamine\/lipopolysaccharide-induced fulminant hepatic failure","volume":"29","author":"Ben Ari","year":"2012","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.apsb.2026.04.014_bib194","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1440-1746.2008.05770.x","article-title":"Therapeutic approach to regulate innate immune response by toll-like receptor 4 antagonist E5564 in rats with D-galactosamine-induced acute severe liver injury","volume":"24","author":"Kitazawa","year":"2009","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib195","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04715-22","article-title":"Retracted and republished from: \u201cgut microbiota mediates the therapeutic effect of monoclonal anti-TLR4 antibody on acetaminophen-induced acute liver injury in mice.\u201d","volume":"11","author":"Sun","year":"2023","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.apsb.2026.04.014_bib196","doi-asserted-by":"crossref","first-page":"G1319","DOI":"10.1152\/ajpgi.00140.2010","article-title":"Lipopolysaccharide binding protein inhibitory peptide protects against acetaminophen-induced hepatotoxicity","volume":"299","author":"Su","year":"2010","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib197","first-page":"653","article-title":"Hepatic macrophage activation and the LPS pathway in patients with different degrees of severity and histopathological patterns of drug induced liver injury","volume":"36","author":"Du","year":"2021","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.apsb.2026.04.014_bib198","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1038\/s41423-020-00592-6","article-title":"Gut microbiome, liver immunology, and liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib199","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and Kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106566","article-title":"Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases","volume":"187","author":"Xiang","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib201","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/hep.29802","article-title":"Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: an international collaborative effort","volume":"69","author":"Church","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib202","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jlb.67.1.97","article-title":"Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli","volume":"67","author":"Buechler","year":"2000","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2026.04.014_bib203","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1182\/blood-2008-07-167064","article-title":"The macrophage scavenger receptor CD163 functions as an innate immune sensor for bacteria","volume":"113","author":"Fabriek","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.04.014_bib204","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1089\/ars.2012.4834","article-title":"CD163 and inflammation: biological, diagnostic, and therapeutic aspects","volume":"18","author":"Etzerodt","year":"2013","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2026.04.014_bib205","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1189\/jlb.72.4.711","article-title":"Endotoxin induces rapid metalloproteinase-mediated shedding followed by up-regulation of the monocyte hemoglobin scavenger receptor CD163","volume":"72","author":"Hintz","year":"2002","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2026.04.014_bib206","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2007.05.014","article-title":"Soluble CD163 from activated macrophages predicts mortality in acute liver failure","volume":"47","author":"M\u00f8ller","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib207","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s00535-004-1493-8","article-title":"Soluble CD163 in patients with liver diseases: very high levels of soluble CD163 in patients with fulminant hepatic failure","volume":"40","author":"Hiraoka","year":"2005","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0014-5793(02)03142-3","article-title":"Only the soluble form of the scavenger receptor CD163 acts inhibitory on phorbol ester-activated T-lymphocytes, whereas membrane-bound protein has no effect","volume":"526","author":"Frings","year":"2002","journal-title":"FEBS Lett"},{"key":"10.1016\/j.apsb.2026.04.014_bib209","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.803037","article-title":"Macrophage polarization and its role in liver disease","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00204-024-03886-0","article-title":"Innate immune regulation in inflammation resolution and liver regeneration in drug-induced liver injury","volume":"99","author":"Qian","year":"2025","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib211","article-title":"Kupffer cells regulate iNKT cells through IL-12 to mitigate the extent of APAP-induced damage in the liver","volume":"29","author":"Li","year":"2025","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib212","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138510","article-title":"PPAR\u03b1 agonist ameliorates cholestatic liver injury by regulating hepatic macrophage homeostasis","volume":"287","author":"Shi","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.apsb.2026.04.014_bib213","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/ni.1863","article-title":"The role of pattern-recognition receptors in innate immunity: update on toll-like receptors","volume":"11","author":"Kawai","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib214","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1136\/gut.2008.156307","article-title":"Toll-like receptors as targets in chronic liver diseases","volume":"58","author":"Mencin","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.04.014_bib215","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/cmi.2014.110","article-title":"Over-activation of TLR5 signaling by high-dose flagellin induces liver injury in mice","volume":"12","author":"Xiao","year":"2015","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib216","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.toxlet.2021.01.022","article-title":"Exogenous activation of toll-like receptor 5 signaling mitigates acetaminophen-induced hepatotoxicity in mice","volume":"342","author":"Zhou","year":"2021","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.apsb.2026.04.014_bib217","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/hep.29140","article-title":"Toll-like receptor 5 signaling restrains T-cell\/natural killer T-cell activation and protects against concanavalin A-induced hepatic injury","volume":"65","author":"Wang","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib218","doi-asserted-by":"crossref","first-page":"7221","DOI":"10.4049\/jimmunol.181.10.7221","article-title":"CD4+CD25+ Foxp3+ regulatory T cells protect against T cell-mediated fulminant hepatitis in a TGF-\u03b2-dependent manner in mice","volume":"181","author":"Wei","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib219","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s40779-021-00309-4","article-title":"Toll-like receptor 5-mediated signaling enhances liver regeneration in mice","volume":"8","author":"Zhang","year":"2021","journal-title":"Milit Med Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib220","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1038\/s41564-020-00801-y","article-title":"Modifying bacterial flagellin to evade Nod-like receptor CARD 4 recognition enhances protective immunity against Salmonella","volume":"5","author":"Tourlomousis","year":"2020","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib221","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/HEP.0000000000000207","article-title":"The evolving role of liver sinusoidal endothelial cells in liver health and disease","volume":"78","author":"McConnell","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib222","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jhep.2019.02.012","article-title":"Role of liver sinusoidal endothelial cells in non-alcoholic fatty liver disease","volume":"70","author":"Hammoutene","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib223","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jhep.2007.12.005","article-title":"Leukocyte adhesion in the liver: distinct adhesion paradigm from other organs","volume":"48","author":"Lee","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib224","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tox.2008.08.003","article-title":"Lymphocyte recruitment to the liver; molecular insights into the pathogenesis of liver injury and hepatitis","volume":"254","author":"Shetty","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.apsb.2026.04.014_bib225","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41575-018-0020-y","article-title":"Liver sinusoidal endothelial cells\u2014gatekeepers of hepatic immunity","volume":"15","author":"Shetty","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib226","doi-asserted-by":"crossref","first-page":"3067","DOI":"10.3390\/ijms24043067","article-title":"The role of the NLRP3 inflammasome and programmed cell death in acute liver injury","volume":"24","author":"Yu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib227","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-pathmechdis-032521-102529","article-title":"Role of the inflammasome in liver disease","volume":"17","author":"Ribeiro","year":"2021","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.apsb.2026.04.014_bib228","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1021\/acs.chemrestox.9b00275","article-title":"Definition of the chemical and immunological signals involved in drug-induced liver injury","volume":"33","author":"Ali","year":"2020","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib229","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/hep.26697","article-title":"Chemokine receptor CCR6-dependent accumulation of \u03b3\u03b4 T cells in injured liver restricts hepatic inflammation and fibrosis","volume":"59","author":"Hammerich","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib230","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1053\/gast.2003.50098","article-title":"ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-\u03b1\/IL-6 in mice","volume":"124","author":"Selzner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.04.014_bib231","first-page":"4845","article-title":"CXCL9 regulates acetaminophen-induced liver injury via CXCR3","volume":"18","author":"Song","year":"2019","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib232","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1007\/s11427-025-2942-8","article-title":"Liver sinusoidal endothelial cells secret C\u2013X\u2013C motif chemokine ligand 10 to promote the recruitment of invariant NKT cells in acetaminophen-induced liver injury","volume":"68","author":"Wang","year":"2025","journal-title":"Sci China Life Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib233","article-title":"Intrahepatic infiltration of activated CD8+ T cells and mononuclear phagocyte is associated with idiosyncratic drug-induced liver injury","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"issue":"Supp. 1","key":"10.1016\/j.apsb.2026.04.014_bib234","article-title":"High-dimensional cytometry for single-cell immune profiling uncovers immunopathological mechanisms in idiosyncratic drug-induced liver injury (DILI)","volume":"82","author":"Lucena","year":"2025","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib235","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.26709","article-title":"Hepatic histological findings in suspected drug-induced liver injury: systematic evaluation and clinical associations","volume":"59","author":"Kleiner","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib236","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/cei.12558","article-title":"Comparative analysis of portal hepatic infiltrating leucocytes in acute drug-induced liver injury, idiopathic autoimmune and viral hepatitis","volume":"180","author":"Foureau","year":"2015","journal-title":"Clin Exp Immunol"},{"issue":"11","key":"10.1016\/j.apsb.2026.04.014_bib237","doi-asserted-by":"crossref","first-page":"990","DOI":"10.3389\/fphys.2020.00990","article-title":"The role of sinusoidal endothelial cells in the axis of inflammation and cancer within the liver","volume":"11","author":"Wilkinson","year":"2020","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib238","doi-asserted-by":"crossref","first-page":"8011","DOI":"10.3390\/ijms21218011","article-title":"CD4 T helper cell subsets and related human immunological disorders","volume":"21","author":"Zhu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib239","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.jhep.2012.07.008","article-title":"CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver","volume":"57","author":"Oo","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib240","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.intimp.2019.01.005","article-title":"Dual effect of T helper cell 17 (Th17) and regulatory T cell (Treg) in liver pathological process: from occurrence to end stage of disease","volume":"69","author":"Zhang","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib241","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115422","article-title":"Th17\/Treg imbalance mediates hepatic intolerance to exogenous lipopolysaccharide and exacerbates liver injury in triptolide induced excessive immune response","volume":"295","author":"Zhang","year":"2022","journal-title":"J Ethnopharmacol"},{"issue":"Pt 3","key":"10.1016\/j.apsb.2026.04.014_bib242","article-title":"Gut microbiota contributes to the intestinal and extraintestinal immune homeostasis by balancing Th17\/Treg cells","volume":"143","author":"Wang","year":"2024","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"10.1016\/j.apsb.2026.04.014_bib243","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1038\/s41467-017-01917-2","article-title":"Remodelling of the gut microbiota by hyperactive NLRP3 induces regulatory T cells to maintain homeostasis","volume":"8","author":"Yao","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.04.014_bib244","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.4110\/in.2022.22.e46","article-title":"Context-dependent regulation of type17 immunity by microbiota at the intestinal barrier","volume":"22","author":"Akuzum","year":"2022","journal-title":"Immune Netw"},{"key":"10.1016\/j.apsb.2026.04.014_bib245","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/imm.13028","article-title":"Interleukin-17\/interleukin-17 receptor axis elicits intestinal neutrophil migration, restrains gut dysbiosis and lipopolysaccharide translocation in high-fat diet-induced metabolic syndrome model","volume":"156","author":"P\u00e9rez","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.apsb.2026.04.014_bib246","doi-asserted-by":"crossref","first-page":"56","DOI":"10.37349\/edd.2023.00018","article-title":"Immunophenotyping to improve the mechanistic understanding of idiosyncratic drug-induced liver injury: clinical implications and future directions","volume":"2","author":"Cueto-S\u00e1nchez","year":"2023","journal-title":"Explor Dig Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib247","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jhep.2020.05.047","article-title":"Blocking integrin \u03b14\u03b27-mediated CD4 T cell recruitment to the intestine and liver protects mice from Western diet-induced non-alcoholic steatohepatitis","volume":"73","author":"Rai","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib248","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2468-1253(24)00390-X","article-title":"The intestinal barrier: a pivotal role in health, inflammation, and cancer","volume":"10","author":"Neurath","year":"2025","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib249","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.gastro.2015.10.046","article-title":"Leukocyte trafficking to the small intestine and colon","volume":"150","author":"Habtezion","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.04.014_bib250","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial CCL25 mediates the recruitment of CCR9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib251","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.3389\/fimmu.2019.01582","article-title":"The roles of liver-resident lymphocytes in liver diseases","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib252","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3390\/cells13090756","article-title":"Selective targeting of \u03b14\u03b27\/MAdCAM-1 axis suppresses fibrosis progression by reducing proinflammatory T cell recruitment to the liver","volume":"13","author":"Gupta","year":"2024","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.04.014_bib253","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/j.jcmgh.2020.12.003","article-title":"MAdCAM-1\/\u03b14\u03b27 integrin-mediated lymphocyte\/endothelium interactions exacerbate acute immune-mediated hepatitis in mice","volume":"11","author":"Schippers","year":"2021","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib254","series-title":"Drug-Induced liver disease","first-page":"135","article-title":"Liver sinusoidal endothelial cells and liver injury","author":"DeLeve","year":"2013"},{"key":"10.1016\/j.apsb.2026.04.014_bib255","first-page":"417","article-title":"Clinical value of serum soluble intercellular adhesion molecule-1 in patients with primary biliary cirrhosis and autoimmune hepatitis","volume":"30","author":"Qing","year":"2014","journal-title":"J Clin Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib256","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/hepr.12304","article-title":"Soluble intracellular adhesion molecule, M30 and M65 as serum markers of disease activity and prognosis in cholestatic liver diseases","volume":"44","author":"Denk","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib257","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/JLB.2MR0220-549R","article-title":"ICAM-1: a master regulator of cellular responses in inflammation, injury resolution, and tumorigenesis","volume":"108","author":"Bui","year":"2020","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.apsb.2026.04.014_bib258","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/s41564-021-00948-2","article-title":"Crosstalk between \u03b3\u03b4 T cells and the microbiota","volume":"6","author":"Papotto","year":"2021","journal-title":"Nat Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib259","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/microorganisms9020296","article-title":"Pathophysiological roles of mucosal-associated invariant T cells in the context of gut microbiota-liver axis","volume":"9","author":"Gebru","year":"2021","journal-title":"Microorganisms"},{"key":"10.1016\/j.apsb.2026.04.014_bib260","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20232298","article-title":"MAIT cells: conserved watchers on the wall","volume":"222","author":"Germain","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib261","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3748\/wjg.v26.i20.2559","article-title":"Role of \u03b3\u03b4T cells in liver diseases and its relationship with intestinal microbiota","volume":"26","author":"Zhou","year":"2020","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib262","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1053\/j.gastro.2018.02.019","article-title":"Alterations in intestinal microbiota lead to production of interleukin 17 by intrahepatic \u03b3\u03b4 T-cell receptor\u2013positive cells and pathogenesis of cholestatic liver disease","volume":"154","author":"Tedesco","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.04.014_bib263","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/hep.25982","article-title":"High-mobility group box 1 (HMGB1)-toll-like receptor (TLR)4-interleukin (IL)-23-IL-17A axis in drug-induced damage-associated lethal hepatitis: interaction of \u03b3\u03b4 T cells with macrophages","volume":"57","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib264","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1149506","article-title":"Infiltrated IL-17A-producing gamma delta T cells play a protective role in sepsis-induced liver injury and are regulated by CCR6 and gut commensal microbes","volume":"13","author":"Wan","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib265","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.4049\/jimmunol.1501774","article-title":"\u03b3\u03b4 T cells protect the liver and lungs of mice from autoimmunity induced by scurfy lymphocytes","volume":"196","author":"Ujiie","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib266","doi-asserted-by":"crossref","first-page":"5007","DOI":"10.4049\/jimmunol.1101315","article-title":"V\u03b34 \u03b3\u03b4 T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis","volume":"187","author":"Zhao","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib267","article-title":"\u0393\u03b4T cells suppress liver fibrosis via strong cytolysis and enhanced NK cell-mediated cytotoxicity against hepatic stellate cells","volume":"10","author":"Liu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib268","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.3389\/fimmu.2020.01014","article-title":"MAIT cell activation and functions","volume":"11","author":"Hinks","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib269","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1002\/hep.29782","article-title":"MAIT cells are chronically activated in patients with autoimmune liver disease and promote profibrogenic hepatic stellate cell activation","volume":"68","author":"B\u00f6ttcher","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib270","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/eji.201847608","article-title":"Primary sclerosing cholangitis leads to dysfunction and loss of MAIT cells","volume":"48","author":"von Seth","year":"2018","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib271","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2001930","volume":"15","author":"Shaler","year":"2017","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2026.04.014_bib272","doi-asserted-by":"crossref","first-page":"3705","DOI":"10.3748\/wjg.v27.i25.3705","article-title":"Incorporating mucosal-associated invariant T cells into the pathogenesis of chronic liver disease","volume":"27","author":"Czaja","year":"2021","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib273","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1432651","article-title":"Insights into the tissue repair features of MAIT cells","volume":"15","author":"Gao","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib274","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/ni.3854","article-title":"Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes","volume":"18","author":"Rouxel","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib275","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01994","article-title":"Mucosal-associated invariant T cells improve nonalcoholic fatty liver disease through regulating macrophage polarization","volume":"9","author":"Li","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib276","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/ni.3679","article-title":"Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells","volume":"18","author":"Keller","year":"2017","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.04.014_bib277","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2439534","article-title":"Dietary modulation of gut microbiota affects susceptibility to drug-induced liver injury","volume":"16","author":"Pan","year":"2024","journal-title":"Gut Microbes"},{"key":"10.1016\/j.apsb.2026.04.014_bib278","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3390\/cimb46020078","article-title":"Gut\u2013liver axis as a therapeutic target for drug-induced liver injury","volume":"46","author":"Tao","year":"2024","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.apsb.2026.04.014_bib279","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s00253-021-11646-8","article-title":"Probiotics, prebiotics and synbiotics: safe options for next-generation therapeutics","volume":"106","author":"Yadav","year":"2022","journal-title":"Appl Microbiol Biotechnol"},{"key":"10.1016\/j.apsb.2026.04.014_bib280","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111000","article-title":"Lactobacillus reuteri DSM 17938 alleviates D-galactosamine-induced liver failure in rats","volume":"133","author":"Jiang","year":"2021","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.04.014_bib281","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00384-21","article-title":"Lactobacillus acidophilus LA14 alleviates liver injury","volume":"6","author":"Lv","year":"2021","journal-title":"mSystems"},{"key":"10.1016\/j.apsb.2026.04.014_bib282","doi-asserted-by":"crossref","first-page":"632","DOI":"10.3390\/nu12030632","article-title":"Probiotic Bacillus spores protect against acetaminophen induced acute liver injury in rats","volume":"12","author":"Neag","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.apsb.2026.04.014_bib283","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.freeradbiomed.2023.03.026","article-title":"Bifidobacterium longum R0175 protects mice against APAP-induced liver injury by modulating the Nrf2 pathway","volume":"203","author":"Li","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib284","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/liv.15512","article-title":"Ampicillin exacerbates acetaminophen-induced acute liver injury by inducing intestinal microbiota imbalance and butyrate reduction","volume":"43","author":"Li","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.apsb.2026.04.014_bib285","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1007\/s42770-020-00302-4","article-title":"Effect of probiotic supplementation on oxidative stress markers in rats with diclofenac-induced hepatotoxicity","volume":"51","author":"Riane","year":"2020","journal-title":"Braz J Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib286","doi-asserted-by":"crossref","first-page":"5075","DOI":"10.1007\/s12602-025-10464-y","article-title":"Probiotic Limosilactobacillus reuteri DSM 17938 alleviates acute liver injury by activating the AMPK signaling via gut microbiota-derived propionate","volume":"17","author":"Zhao","year":"2025","journal-title":"Probiotics Antimicrob Proteins"},{"key":"10.1016\/j.apsb.2026.04.014_bib287","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13578-025-01370-5","article-title":"Gram-positive probiotics improves acetaminophen-induced hepatotoxicity by inhibiting leucine and Hippo-YAP pathway","volume":"15","author":"Gao","year":"2025","journal-title":"Cell Biosci"},{"key":"10.1016\/j.apsb.2026.04.014_bib288","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.3389\/fmicb.2017.01804","article-title":"Protective effect of Akkermansia muciniphila against immune-mediated liver injury in a mouse model","volume":"8","author":"Wu","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib289","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00484-21","article-title":"The protective effects of live and pasteurized Akkermansia muciniphila and its extracellular vesicles against HFD\/CCl4-induced liver injury","volume":"9","author":"Keshavarz Azizi Raftar","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.apsb.2026.04.014_bib290","article-title":"Bacteroides fragilis 839 ameliorates anti-tuberculosis drugs-induced liver injury by suppressing inflammation and regulating gut microbiota in mice","volume":"12","author":"Li","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.apsb.2026.04.014_bib291","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41575-021-00440-6","article-title":"The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics","volume":"18","author":"Salminen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib292","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.fct.2010.11.041","article-title":"Modulation of Bax\/Bcl-2 and caspases by probiotics during acetaminophen induced apoptosis in primary hepatocytes","volume":"49","author":"Sharma","year":"2011","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib293","doi-asserted-by":"crossref","first-page":"594","DOI":"10.3389\/fmicb.2017.00594","article-title":"Lactobacillus fermentum postbiotic-induced autophagy as potential approach for treatment of acetaminophen hepatotoxicity","volume":"8","author":"Dini\u0107","year":"2017","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib294","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1096\/fj.201900927RR","article-title":"Butyrate prevents valproate-induced liver injury: in vitro and in vivo evidence","volume":"34","author":"Pirozzi","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.04.014_bib295","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1080\/21655979.2021.2024970","article-title":"4-Phenylbutyrate protects against rifampin-induced liver injury via regulating MRP2 ubiquitination through inhibiting endoplasmic reticulum stress","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"key":"10.1016\/j.apsb.2026.04.014_bib296","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.phrs.2014.06.003","article-title":"Protection afforded by pre- or post-treatment with 4-phenylbutyrate against liver injury induced by acetaminophen overdose in mice","volume":"87","author":"Shimizu","year":"2014","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib297","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.tox.2017.01.002","article-title":"Pyrazinamide-induced hepatotoxicity is alleviated by 4-PBA via inhibition of the PERK\u2013eIF2\u03b1\u2013ATF4\u2013CHOP pathway","volume":"378","author":"Guo","year":"2017","journal-title":"Toxicology"},{"key":"10.1016\/j.apsb.2026.04.014_bib298","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00535-016-1256-3","article-title":"Sodium 4-phenylbutyric acid prevents murine acetaminophen hepatotoxicity by minimizing endoplasmic reticulum stress","volume":"52","author":"Kusama","year":"2017","journal-title":"J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib299","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.7150\/ijbs.69116","article-title":"Urolithin A protects against acetaminophen-induced liver injury in mice via sustained activation of Nrf2","volume":"18","author":"Gao","year":"2022","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib300","article-title":"The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota","volume":"2","author":"Blake","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.apsb.2026.04.014_bib301","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jpha.2019.11.003","article-title":"Vancomycin pretreatment attenuates acetaminophen-induced liver injury through 2-hydroxybutyric acid","volume":"10","author":"Zheng","year":"2020","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.apsb.2026.04.014_bib302","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107275","article-title":"Lactobacillus rhamnosus GG ameliorates triptolide-induced liver injury through modulation of the bile acid-FXR axis","volume":"206","author":"Hu","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib303","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1440-1746.2001.02376.x","article-title":"Use of ursodeoxycholic acid in liver diseases","volume":"16","author":"Kumar","year":"2001","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib304","first-page":"192","article-title":"Ursodeoxycholic acid in treatment of non-cholestatic liver diseases: a systematic review","volume":"4","author":"Reardon","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib305","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.744488","article-title":"Role of ursodeoxycholic acid in treating and preventing idiosyncratic drug-induced liver injury. A systematic review","volume":"12","author":"Robles-D\u00edaz","year":"2021","journal-title":"Front Pharmacol"},{"issue":"1 Suppl","key":"10.1016\/j.apsb.2026.04.014_bib306","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/j.jhep.2015.02.023","article-title":"New paradigms in the treatment of hepatic cholestasis: from UDCA to FXR, PXR and beyond","volume":"62","author":"Beuers","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib307","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.04.014_bib308","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/mol.119.118646","article-title":"Obeticholic acid ameliorates valproic acid-induced hepatic steatosis and oxidative stress","volume":"97","author":"Gai","year":"2020","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib309","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/toxsci\/kfw098","article-title":"Pyrazinamide induced rat cholestatic liver injury through inhibition of FXR regulatory effect on bile acid synthesis and transport","volume":"152","author":"Guo","year":"2016","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.apsb.2026.04.014_bib310","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1080\/00498254.2021.1900626","article-title":"FXR activation prevents liver injury induced by Tripterygium wilfordii preparations","volume":"51","author":"Peng","year":"2021","journal-title":"Xenobiotica"},{"key":"10.1016\/j.apsb.2026.04.014_bib311","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2022.113208","article-title":"Gut microbiota mediates methamphetamine-induced hepatic inflammation via the impairment of bile acid homeostasis","volume":"166","author":"Zhang","year":"2022","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.apsb.2026.04.014_bib312","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2022.116251","article-title":"Identification of a novel farnesoid X receptor agonist, kaempferol-7-O-rhamnoside, a compound ameliorating drug-induced liver injury based on virtual screening and in vitro validation","volume":"454","author":"Liu","year":"2022","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib313","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.1027731","article-title":"Ginsenoside Rc, as an FXR activator, alleviates acetaminophen-induced hepatotoxicity via relieving inflammation and oxidative stress","volume":"13","author":"Zhong","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.04.014_bib314","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i28.105089","article-title":"Fecal microbiota transplantation: a promising treatment strategy for chronic liver disease","volume":"31","author":"Ma","year":"2025","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib315","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/gutjnl-2018-316818","article-title":"The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines","volume":"67","author":"Mullish","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.04.014_bib316","doi-asserted-by":"crossref","DOI":"10.3748\/wjg.v31.i28.105089","article-title":"Fecal microbiota transplantation: a promising treatment strategy for chronic liver disease","volume":"31","author":"Ma","year":"2025","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2026.04.014_bib317","first-page":"345","article-title":"Probiotics enhance the efficacy of fecal microbiota transplantation in severe acute liver injury","volume":"28","author":"Fan","year":"2020","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"10.1016\/j.apsb.2026.04.014_bib318","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41598-021-81263-y","article-title":"Fecal transplantation alleviates acute liver injury in mice through regulating Treg\/Th17 cytokines balance","volume":"11","author":"Liu","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib319","article-title":"Oral fecal transplantation enriches Lachnospiraceae and butyrate to mitigate acute liver injury","volume":"43","author":"Yang","year":"2024","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.04.014_bib320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182977","article-title":"Fructose diet alleviates acetaminophen-induced hepatotoxicity in mice","volume":"12","author":"Cho","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.04.014_bib321","doi-asserted-by":"crossref","first-page":"20","DOI":"10.20517\/mtod.2023.28","article-title":"Fructose as a novel nutraceutical for acetaminophen (APAP)-induced hepatotoxicity","volume":"3","author":"Rodrigues","year":"2023","journal-title":"Metab Target Organ Damage"},{"key":"10.1016\/j.apsb.2026.04.014_bib322","article-title":"Dietary patterns and the risk of tuberculosis-drug-induced liver injury: a cohort study","volume":"11","author":"Wang","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.apsb.2026.04.014_bib323","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2022.12.040","article-title":"The evolving profile of idiosyncratic drug-induced liver injury","volume":"21","author":"Fontana","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2023.107046","article-title":"Roadmap to DILI research in Europe. a proposal from COST action ProEuroDILINet","volume":"200","author":"Lucena","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.04.014_bib325","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgae070","article-title":"Gut\u2013liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism","volume":"3","author":"Kurniawan","year":"2024","journal-title":"PNAS Nexus"},{"key":"10.1016\/j.apsb.2026.04.014_bib326","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1146\/annurev-pathmechdis-031521-024831","article-title":"Spatiotemporal metabolic liver zonation and consequences on pathophysiology","volume":"18","author":"Martini","year":"2023","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.apsb.2026.04.014_bib327","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1620829","article-title":"Bacterial extracellular vesicles: emerging mediators of gut\u2013liver axis crosstalk in hepatic diseases","volume":"15","author":"Zhou","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib328","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12303","article-title":"Faeces-derived extracellular vesicles participate in the onset of barrier dysfunction leading to liver diseases","volume":"12","author":"Fizanne","year":"2023","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.04.014_bib329","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12474","article-title":"Characterisation of LPS+ bacterial extracellular vesicles along the gut-hepatic portal vein-liver axis","volume":"13","author":"Jain","year":"2024","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.04.014_bib330","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70240","article-title":"An exploratory study on the pathogenic role of faecal extracellular vesicles in metabolic dysfunction-associated steatotic liver disease progression and in drug-induced liver injury","volume":"15","author":"Ruiz-Malag\u00f3n","year":"2026","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.04.014_bib331","doi-asserted-by":"crossref","first-page":"818","DOI":"10.3390\/antiox12040818","article-title":"Membrane vesicles of toxigenic Clostridioides difficile affect the metabolism of liver HepG2 cells","volume":"12","author":"Caballano-Infantes","year":"2023","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.apsb.2026.04.014_bib332","doi-asserted-by":"crossref","first-page":"G485","DOI":"10.1152\/ajpgi.00362.2020","article-title":"Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut\u2013liver axis?.","volume":"320","author":"Villard","year":"2021","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib333","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3390\/gastroent14040041","article-title":"Microbiome and genetic factors in the pathogenesis of liver diseases","volume":"14","author":"Miteva","year":"2023","journal-title":"Gastroenterol Insights"},{"key":"10.1016\/j.apsb.2026.04.014_bib334","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/gutjnl-2024-332398","article-title":"Interplay between gut microbiome, host genetic and epigenetic modifications in MASLD and MASLD-related hepatocellular carcinoma","volume":"74","author":"Ha","year":"2024","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.04.014_bib335","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.mib.2013.05.004","article-title":"Striking a balance: fungal commensalism versus pathogenesis","volume":"16","author":"Iliev","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.apsb.2026.04.014_bib336","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/s41575-023-00816-w","article-title":"Commensal fungi in intestinal health and disease","volume":"20","author":"Ost","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2026.04.014_bib337","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1012377","article-title":"Gut mycobiome alterations and implications for liver diseases","volume":"20","author":"Zeng","year":"2024","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.apsb.2026.04.014_bib338","article-title":"IDDF2023-ABS-0120 Candida derived \u03b2-glucan protects against lipopolysaccharide and D-galactosamine-induced fatal hepatitis","volume":"72","author":"Cai","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.apsb.2026.04.014_bib339","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/hep.31459","article-title":"Intestinal virome in patients with alcoholic hepatitis","volume":"72","author":"Jiang","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2026.04.014_bib340","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.dld.2015.07.008","article-title":"The human gut microbiota and virome: potential therapeutic implications","volume":"47","author":"Scarpellini","year":"2015","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.apsb.2026.04.014_bib341","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.199","article-title":"A new evaluation system for drug\u2013microbiota interactions","volume":"3","author":"Liu","year":"2024","journal-title":"iMeta"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526002625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T20:11:24Z","timestamp":1783714284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526002625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":341,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2211383526002625"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.04.014","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The gut\u2013liver axis in drug-induced liver injury (DILI): Interplay between gut microbiota, intestinal barrier, and immune system","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}